Cetrorelix

DRUG20 trials

Sponsors

Assistance Publique Hopitaux De Paris, Solvay Pharmaceuticals, Nippon Kayaku Co., Ltd., Betanien Hospital, Ferring Pharmaceuticals

Conditions

ARTAssisted ReproductionAssisted Reproductive TechnologyControlled Ovarian HyperstimulationEndometriosisFertilityIVFIVF (In vitro fertilization) or ICSI (intracytoplasmic sperm injection) protocol with embryo transfer planned on the same cycle.

Phase 2

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

CompletedNCT00244452

Solvay PharmaceuticalsEndometriosis

Start: 2005-11-30End: 2006-09-30Updated: 2008-03-31

Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis

CompletedNCT00667758

Betanien HospitalRheumatoid Arthritis

Start: 2008-05-31End: 2011-10-31Updated: 2012-08-06

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

CompletedNCT02784457

Ain Shams UniversityAssisted Reproduction

Start: 2014-06-30End: 2016-03-31Updated: 2016-05-27

Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome

Benha UniversityInfertility

Start: 2014-10-31End: 2017-05-31Updated: 2017-03-30

Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

Bio Genuine (Shanghai) Biotech Co., Ltd.Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation

Start: 2023-08-31End: 2024-12-31Target: 240Updated: 2023-07-27

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization

Beni-Suef UniversityIVF, PCO

Start: 2023-08-20End: 2023-09-30Target: 200Updated: 2023-08-03

Phase 3

SOLOAGO - Luteal phase support by GnRH agonist alone after GnRH agonist triggering compared to the reference protocol (hCG triggering and luteal support with progesterone) in IVF: a randomized controlled trial.

RecruitingCTIS2023-505126-34-00

Assistance Publique Hopitaux De ParisIVF (In vitro fertilization) or ICSI (intracytoplasmic sperm injection) protocol with embryo transfer planned on the same cycle.

Start: 2024-06-27Target: 652Updated: 2025-05-21

Phase 4

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)

CompletedNCT01225835

Ferring PharmaceuticalsInfertility

Start: 2010-10-31End: 2013-06-30Updated: 2014-03-14

Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

CompletedNCT03118830

Cairo UniversityInvitro Fertilization

Start: 2017-04-21End: 2017-11-03Updated: 2017-11-07

Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection

Assiut UniversityPolycystic Ovary Syndrome

Start: 2019-12-07End: 2021-01-31Target: 150Updated: 2020-03-25

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

CompletedNCT04724343

Damascus UniversityInfertility, Intracytoplasmic Sperm Injection, In Vitro Fertilization

Start: 2019-12-22End: 2022-07-05Updated: 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

CompletedNCT04724486

Damascus UniversityInfertility, Intracytoplasmic Sperm Injection, In Vitro Fertilization

Start: 2020-08-22End: 2022-07-15Updated: 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

CompletedNCT04727684

Damascus UniversityInfertility, Intracytoplasmic Sperm Injection, In Vitro Fertilization +1

Start: 2020-08-22End: 2022-05-12Updated: 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

CompletedNCT04727671

Damascus UniversityInfertility, Intracytoplasmic Sperm Injection, In Vitro Fertilization +1

Start: 2019-12-22End: 2021-12-30Updated: 2023-10-24

Unknown Phase

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

CompletedNCT00628121

Nippon Kayaku Co., Ltd.Premenopause

Start: 2006-04-30End: 2007-02-28Updated: 2008-03-04

Reproductive Hormonal Alterations in Obesity

CompletedNCT01457703

University of Colorado, DenverObesity

Start: 2010-06-30End: 2013-07-31Updated: 2017-01-12

Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days

CompletedNCT01468441

Fertility - Assisted Fertilization CenterInfertility

Start: 2011-09-30End: 2012-03-31Updated: 2012-07-13

Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

Southern Cross Fertility CentreInfertility

Start: 2012-04-30End: 2012-11-30Target: 300Updated: 2012-05-25

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

CompletedNCT02478775

University of Colorado, DenverFertility, Obesity

Start: 2015-07-31End: 2021-06-30Updated: 2024-06-05

Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF

TerminatedNCT03680053

ShangHai Ji Ai Genetics & IVF InstituteART, Infertility

Start: 2020-04-10End: 2025-05-10Updated: 2025-05-31

Related Papers

Effects of pulsatile intravenous follicle-stimulating hormone treatment on ovarian function in women with obesity

Fertility and Sterility2023-06-036 citations

Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.

2017-11-134 citations

Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial

PLoS ONE2015-10-1322 citations

Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments.

2013-02-0515 citations